THE TRUTH ABOUT: Taro org - Caught on Camera

FDA Recalls 90,000 Children's Ibuprofen Bottles Nationwide After Consumers Report Black Particles, Gel Mass

FDA Class II recall: Nearly 90,000 bottles of children's ibuprofen by Strides Pharma contaminated with black particles. Check lot numbers 7261973A and 7261974A to ensure safety. Learn about potential health risks and next steps.

International Business Times UK · Mar 20

Spain's Wottan Rebbe 401 Retro-Style Naked Bike Is Perfect For the US Market

If we take a look at today’s motorcycle market, what will we notice? Well, for starters, we’ll see massive adventure bikes with way too much power and way too much tech commanding upwards of $30,000. We’ll also see a middleweight segment that’s becoming more and more infused with technology.Much to…

RideApart · Nov 8, 2024

3 A-Rated Pharma Stocks to Buy for Long-Term Growth

With surging medical needs, advances in precision medicine, and the adoption of generative AI, the pharmaceutical industry is thriving. Thus, it could be ideal to invest in quality pharma stocks Taro Pharmaceutical (TARO), AstraZeneca (AZN), and Merck (MRK) for long-term growth. These stocks are rated A (Strong Buy) in our…

StockNews.com · May 2, 2024

3 High-Performing Pharma Stocks to Boost Your Portfolio

The growing adoption of innovative drugs is expected to boost the pharmaceutical industry. Therefore, it might be wise to buy fundamentally strong pharma stocks Taro Pharmaceutical (TARO), AstraZeneca (AZN) and AbbVie (ABBV) to boost your portfolio. Read on….

StockNews.com · Oct 20, 2023

3 Pharma Stocks Smart Money Is Following in September

With the rising prevalence of chronic diseases, the demand for pharmaceutical products is anticipated to rise. Therefore, investors could consider buying three fundamentally robust pharma stocks, Eli Lilly and Company (LLY), Zoetis (ZTS), and Taro Pharmaceutical Industries (TARO), which are gaining traction among institutional investors this month. Learn more….

StockNews.com · Sep 5, 2023

3 Pharma Stocks to Buy for Value Investors

The pharma industry is well-positioned to witness significant growth due to the continuous advancements in artificial intelligence and increasing demand for innovative drugs. Therefore, fundamentally strong pharma stocks Merck & Co. (MRK), Astellas Pharma (ALPMY), and Taro Pharmaceutical (TARO), which seem to be trading at a discount, might be solid…

StockNews.com · Aug 7, 2023

Buy These 3 Pharma Stocks in July

The pharmaceutical industry looks well-positioned for long term growth due to the globalization of the industry, increasing investments to develop life-saving drugs, rise in chronic diseases, and a rapidly aging population. To that end, it could be wise to buy fundamentally strong pharma stocks Amphastar Pharmaceuticals (AMPH), Ironwood Pharmaceuticals (IRWD),…

StockNews.com · Jul 7, 2023

3 Momentum Stocks Leveling Up for Profits

Amid rising fear of recession, the market is expected to remain volatile. Therefore, it could be wise for investors to buy quality stocks Taro Pharmaceutical Industries (TARO), Tennant (TNC), and Carrols Restaurant (TAST), which have soared over the past months and are leveling up for profits. Read more.

StockNews.com · Jun 2, 2023

5 High Growth Stocks to Buy Amid a Volatile Market

Concerns over aggressive interest rate hikes to fight the multi-decade high inflation and a looming recession have recently kept the stock market under pressure. However, growth stocks Taro Pharmaceutical (TARO), Superior Industries (SUP), Viavi Solutions (VIAV), CEVA (CEVA), and SMART Global Holdings (SGH) are well-positioned to rebound.

StockNews.com · May 26, 2022

3 Healthcare Stocks Trading Near 52-Week Lows to Buy This Month

The healthcare industry is growing rapidly amid increasing demand from an aging population and digital transformation in health systems and technologies, among other factors. And because clinical innovation is expected to continue in the healthcare sector this year, we think it could be profitable to invest in these fundamentally sound…

StockNews.com · Feb 14, 2022